Prescription drug · ANDA
Pellix (Calcipotriene) NDC 87143-300
Calcipotriene .05 mg/mL · Solution · Topical · Perfero Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 87143-300-60 | 87143030060 | 1 BOTTLE, PLASTIC in 1 CARTON (87143-300-60) / 60 mL in 1 BOTTLE, PLASTICMarketed from May 4, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pellix
- Generic name (nonproprietary)
- calcipotriene
- Active ingredients
- Calcipotriene — .05 mg/mL
- Dosage form
- Solution
- Route
- Topical
- Labeler
- Perfero Pharma, Inc.NDC labeler code 87143
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078468
- Marketing start
- Listing expires
- Other FDA classes
- Vitamin D (Chemical structure)
- Identifiers
- Product ID 87143-300_ba4b6a09-9cc9-4617-8c81-b09ecca5fb9eSPL ID ba4b6a09-9cc9-4617-8c81-b09ecca5fb9eSPL set ID 492ea9cf-0117-4d84-a964-9c0121706ed3RxCUI 308865, 2742555UNII 143NQ3779B
- Pharmacologic class
- Vitamin D Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N487143030060followed by a unit qualifier and the quantityPackage 87143-0300-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Pellix™ (calcipotriene) Topical Solution, 0.005% (Scalp Solution) is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.
Excerpt only. Read the full label for complete information.
About NDC 87143-300
- What is NDC 87143-300?
- 87143-300 is the product NDC for Pellix (calcipotriene), Calcipotriene .05 mg/mL solution, listed with the FDA by Perfero Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Pellix (Calcipotriene).
- What is the active ingredient?
- Calcipotriene.
- Who is the labeler?
- Perfero Pharma, Inc., NDC labeler code 87143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Pellix?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 078468
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Calcipotriene | Calcipotriene .05 mg/mL | SolutionTopical | Cosette Pharmaceuticals, Inc. | 0713-0318 |